Cite
HARVARD Citation
Mease, P. et al. (2014). SAT0408 Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials. Annals of the rheumatic diseases. pp. 742-743. [Online].